Home > Healthcare > Healthcare IT > Artificial Intelligence > Cardiac AI Monitoring and Diagnostics Market

Cardiac AI Monitoring and Diagnostics Market Size

  • Report ID: GMI8858
  • Published Date: Apr 2024
  • Report Format: PDF

Cardiac AI Monitoring and Diagnostics Market Size

Cardiac AI Monitoring and Diagnostics Market was valued at around USD 984.7 million in 2023 and is estimated to register a CAGR of over 26.9% between 2024 and 2032. Cardiac AI monitoring and diagnostics encompass the utilization of artificial intelligence (AI) technologies to monitor and diagnose various cardiac conditions. This innovative approach involves the application of machine learning algorithms and data analytics to interpret cardiac data, including electrocardiograms (ECGs), echocardiograms, cardiac MRI scans, and patient demographics. By analyzing these data sets, AI systems can identify anomalies, predict cardiovascular risks, detect arrhythmias, monitor heart failure progression, analyze cardiac imaging, and personalize treatment plans. The increasing technological advancement in cardiac AI monitoring and diagnostics is significant driving factor for the market.

 

For instance, according to National Library of Medicine, in 2023, AI technologies, including machine learning algorithms such as logistic regression for estimating the likelihood of cardiovascular diseases, deep learning models for precise analysis of cardiovascular images, natural language processing for extracting relevant information from clinical documents, and computer-aided diagnosis systems for offering diagnostic recommendations to clinicians by analyzing medical images, are revolutionizing the field of cardiovascular healthcare. These technologies play a crucial role in improving diagnosis, treatment management, and risk prediction of cardiac diseases.

 

Furthermore, growing prevalence of cardiovascular diseases, growing demand for remote monitoring solutions, and increasing focus on precision medicine, are the contributing factors stimulating the growth of the market.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Industry size for cardiac AI monitoring and diagnostics recorded USD 984.7 million in 2023 and is expected to register 26.9% CAGR from 2024 to 2032, owing to the growing prevalence of cardiovascular diseases, and rising focus on precision medicine.

The hardware segment of the cardiac AI monitoring and diagnostics industry is expected to accumulate USD 5 billion by 2032, due to the enhanced computational power of hardware tools like advanced processors, enabling real-time analysis of cardiac data.

North America industry accounted for USD 399.2 million in revenue in 2023 and is expected to expand at notable CAGR from 2024 to 2032, on account of the high rates of obesity, sedentary lifestyles, and an aging population.

CardiAI, Cleerly, Inc., DiA Imaging Analysis, HeartVista Inc., IDOVEN, Koninklijke Philips N.V., RSIP Vision, Tempus, Ultrasight, Ultromics Limited, Viz.ai, Inc. are some of the major cardiac AI monitoring and diagnostics companies worldwide.

Cardiac AI Monitoring and Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 282
  • Countries covered: 22
  • Pages: 189
 Download Free Sample